Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
Authors:
Open Access
- 29 October 2002
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 87 (10) , 1140-1144
Abstract
Caveolin-1 is a major component of caveolae and plays a regulatory role in several signalling pathways. Caveolin-1 was recently identified as a metastasis-related gene in prostate cancer. The clinical effects of caveolin-1 expression in pancreatic carcinoma, however, remain unknown. In this study, we have investigated the relationship between caveolin-1 expression and the clinicopathologic variables and clinical outcome in 79 patients with pancreatic adenocarcinoma undergoing surgical resection. Caveolin-1 expression was determined by immunohistochemistry, using a polyclonal anti-caveolin-1 antibody. Patients were divided into two groups based on the extent of caveolin-1 expression: a negative expression group (immunoreactivity in less than 50% of cells) and a positive expression group. Positive caveolin-1 immunostaining was detected in 32 cases (40.5% of total), while non-neoplastic ductal epithelium showed little or no staining. Positive caveolin-1 expression was correlated with tumour diameter (P=0.0079), histopathologic grade (P=0.0272) and poor prognosis (P=0.0008). Upon multivariate analysis with Cox's proportional hazards model, positive caveolin-1 expression was shown to be an independent negative predictor for survival (P=0.0358). These results suggest that caveolin-1 overexpression is associated with tumour progression, thereby indicating a poor prognosis for certain patients undergoing surgical resection for pancreatic carcinoma.Keywords
This publication has 31 references indexed in Scilit:
- Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor GeneThe American Journal of Pathology, 2001
- Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in SarcomasThe American Journal of Pathology, 2001
- Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I ReceptorJournal of Biological Chemistry, 2001
- Caveolin-1 Expression Inhibits Wnt/β-Catenin/Lef-1 Signaling by Recruiting β-Catenin to Caveolae Membrane DomainsJournal of Biological Chemistry, 2000
- Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.Journal of the American College of Surgeons, 1999
- Reduction of Caveolin 1 Gene Expression in Lung Carcinoma Cell LinesBiochemical and Biophysical Research Communications, 1999
- Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in VivoJournal of Biological Chemistry, 1998
- Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3)FEBS Letters, 1998
- Japan Pancreatic Cancer RegistryPancreas, 1998
- Long-Term Survival After Curative Resection for Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 1996